A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02001571
A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients
Phase 1
Completed
- Conditions
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2013-02-26
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01798628
A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function
Phase 1
Completed
- Conditions
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2012-11-19
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01715259
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01400555
A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-30
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01362764
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-03-17
- Last Posted Date
- 2014-05-15
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT01088529
A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00912899
- Locations
- 🇺🇸
Columbia Presbyterian Hospital, New York City, New York, United States
🇺🇸St. Vincent's Comprehensive Cancer Center, New York City, New York, United States
🇺🇸UCLA, Los Angeles, California, United States
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-03-19
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 1195
- Registration Number
- NCT00638690
A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2008-01-25
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT00600535
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-06-12
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT00485303
- Locations
- 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸Beth Israel Hospital, Boston, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath